• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Refining the interpretation of post-radiotherapy urinary and bowel outcomes in prostate cancer: A clinical perspective.

作者信息

Chen Shengyi, Fang Yuekun, Cheng Bin

机构信息

Department of Andrology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, China.

Department of Urology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, China.

出版信息

Clin Transl Radiat Oncol. 2025 May 3;53:100973. doi: 10.1016/j.ctro.2025.100973. eCollection 2025 Jul.

DOI:10.1016/j.ctro.2025.100973
PMID:40458378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12127611/
Abstract
摘要

相似文献

1
Refining the interpretation of post-radiotherapy urinary and bowel outcomes in prostate cancer: A clinical perspective.优化前列腺癌放疗后泌尿和肠道结局的解读：临床视角
Clin Transl Radiat Oncol. 2025 May 3;53:100973. doi: 10.1016/j.ctro.2025.100973. eCollection 2025 Jul.
2
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.超分割与常规分割放疗治疗前列腺癌的比较：HYPO-RT-PC 随机、非劣效、III 期临床试验的 5 年结果。
Lancet. 2019 Aug 3;394(10196):385-395. doi: 10.1016/S0140-6736(19)31131-6. Epub 2019 Jun 18.
3
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).Hypofractionated 放疗对前列腺癌患者报告结局的影响：CHHiP 试验（CRUK/06/016）5 年随访结果。
Eur Urol Oncol. 2021 Dec;4(6):980-992. doi: 10.1016/j.euo.2021.07.005. Epub 2021 Sep 3.
4
Functional Outcomes After Localized Prostate Cancer Treatment.局限性前列腺癌治疗后的功能结局。
JAMA. 2024 Jan 23;331(4):302-317. doi: 10.1001/jama.2023.26491.
5
Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer.前瞻性比较有效性研究的 5 年结果，评估局部前列腺癌的外照射放疗联合或不联合低剂量率近距离放疗增敏。
Cancer. 2021 Jun 1;127(11):1912-1925. doi: 10.1002/cncr.33388. Epub 2021 Feb 17.
6
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.超分割与常规分割放疗治疗前列腺癌（HYPO-RT-PC）的比较：一项随机、对照、非劣效、3 期临床试验的患者报告的生活质量结局。
Lancet Oncol. 2021 Feb;22(2):235-245. doi: 10.1016/S1470-2045(20)30581-7. Epub 2021 Jan 11.
7
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.大分割放疗与常规分割放疗用于中危局限性前列腺癌患者的比较：随机、非劣效性3期CHHiP试验的2年患者报告结局
Lancet Oncol. 2015 Dec;16(16):1605-16. doi: 10.1016/S1470-2045(15)00280-6. Epub 2015 Oct 28.
8
Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.比较局部前列腺癌调强放疗和质子束放疗结束时和放疗后 3 个月患者报告的生活质量中肠道和泌尿领域。
Cancer Med. 2020 Nov;9(21):7925-7934. doi: 10.1002/cam4.3414. Epub 2020 Sep 15.
9
Optimizing functional outcomes in prostate cancer: a new perspective on early artificial urinary sphincter implantation before salvage radiotherapy in prostate cancer treatment.优化前列腺癌的功能结局：前列腺癌治疗中挽救性放疗前早期植入人工尿道括约肌的新视角。
Cent European J Urol. 2024;77(4):661-667. doi: 10.5173/ceju.2024.0181. Epub 2024 Nov 30.
10
Long-Term Patient-Reported Bowel and Urinary Quality of Life in Patients Treated with Intensity-Modulated Radiotherapy Versus Intensity-Modulated Proton Therapy for Localized Prostate Cancer.调强放射治疗与调强质子治疗局部前列腺癌患者的长期患者报告的肠道和泌尿生活质量
Curr Oncol. 2025 Apr 2;32(4):212. doi: 10.3390/curroncol32040212.

引用本文的文献

1
Letter to the editor: Reply to Chen et al.致编辑的信：对陈等人的回复
Clin Transl Radiat Oncol. 2025 May 9;53:100979. doi: 10.1016/j.ctro.2025.100979. eCollection 2025 Jul.

本文引用的文献

1
Post-treatment changes in bowel and urinary function in prostate cancer patients treated with moderate or ultra-hypofractionation: A prospective cohort study.中度或超分割放疗的前列腺癌患者治疗后肠道和泌尿功能的变化：一项前瞻性队列研究。
Clin Transl Radiat Oncol. 2025 Apr 7;53:100955. doi: 10.1016/j.ctro.2025.100955. eCollection 2025 Jul.
2
Health-related quality of life trajectories up to 15 years after curative treatment for esophageal cancer: a prospective cohort study.根治性治疗后 15 年内与健康相关的生活质量轨迹：一项前瞻性队列研究。
Int J Surg. 2024 Mar 1;110(3):1537-1545. doi: 10.1097/JS9.0000000000001026.
3
International Urogynecology Consultation: Patient Reported Outcome Measures (PROs) use in the evaluation of patients with pelvic organ prolapse.国际泌尿妇科咨询：在评估盆腔器官脱垂患者时使用患者报告结局测量（PROs）。
Int Urogynecol J. 2022 Oct;33(10):2603-2631. doi: 10.1007/s00192-022-05315-1. Epub 2022 Aug 18.
4
Long-term trajectory of postoperative health-related quality of life in young breast cancer patients: a 15-year follow-up study.年轻乳腺癌患者术后健康相关生活质量的长期轨迹：一项15年的随访研究。
J Cancer Surviv. 2023 Oct;17(5):1416-1426. doi: 10.1007/s11764-022-01165-4. Epub 2022 Mar 12.
5
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.前列腺癌临床局限性治疗的ProtecT随机试验中的患者报告结局：研究设计、基线泌尿、肠道及性功能和生活质量
BJU Int. 2016 Dec;118(6):869-879. doi: 10.1111/bju.13582. Epub 2016 Aug 17.